However, ApoC-III atherogenic lipid particles (ApoC-III-apoB, apoC-III-Lp(a), and apoC-III-apoA-I) do not independently predict risk of CAD events as total ApoC-III do [15]. This evidence concerns the gene APOC3 and coronary artery disorder.